Fannin is actively seeking Therapeutics interns for Summer 2023!  We will host a Virtual Open House on March 2^nd, and applications are due March 17th.  Please feel free to promote these opportunities within your membership.

Fannin primarily in-licenses promising, early-stage therapeutic and medical device technologies from leading academic investigators in the Texas Medical Center and on a national stage. Fannin develops and de-risks these technologies via preclinical work and engineering up through early clinical trials. Additionally, Fannin builds the business model and use case, resulting in strategic partnerships or acquisitions.

Our internship program provides hands-on operational experience in early-stage life science development. Fannin offers two tracks in our internship program: Therapeutics and Medical Devices. Our interns work closely with established and potential portfolio companies, experientially learning about biomedical commercialization. Interns might be tasked with assisting with due diligence, working on market analysis, assisting with product development, or researching and understanding key regulatory requirements. All interns work closely with the core Fannin team to ensure a beneficial and useful experience.

We have had several Interns or Fellows connected to GCCQBS complete our program, and we look forward to receiving interest from more of your members!

Should you have any questions, please contact me or our Associate Principal for Therapeutics, Stephanie Vega, copied in this email.

Serena Miggins
Business Operations Manager
713-966-5844

Related Events

• 

  Save the date: 5th Annual Gulf Coast Consortia Innovative Drug Discovery and Development Conference,

  May 7 – May 8